Embolic Risk Articles & Analysis: Older

2 news found

AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism

(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced the completion of patient enrollment in the Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AV). APEX-AV is a clinical ...

Dec. 7, 2023

ByAngioDynamics, Inc.

Aidoc launches the first ai-based automated notification solution for high-risk pulmonary embolism patients

Aidoc, the leading provider of enterprise AI solutions, announced today the launch of an industry first: an AI-based automated activation solution that facilitates rapid risk assessment and care coordination for high-risk pulmonary embolism (PE) patients. ...

Mar. 3, 2021

ByAidoc

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you